Dodaj produkt

Biomerieux Polska Sp. z o.o.

Biomerieux Polska Sp. z o.o.
Żeromskiego 17, 01-882 Warszawa Dane kontaktowe
tel. Pokaż numer telefonu

Lokalizacja


Nazwa:
Biomerieux Polska Sp. z o.o.
Biomerieux Polska Sp. z o.o.
Ulica:
Żeromskiego 17
Kod pocztowy, miasto:
01-882 Warszawa
Województwo:
mazowieckie
Link:
Kraj:
Polska
Telefon stacjonarny:
Pokaż numer telefonu
Adres E-mail:
Wyślij wiadomość
Strona WWW:
http://www.biomerieux.pl

Informacje o firmie:


Faks:
Pokaż numer telefonu
Strona WWW:
http://www.biomerieux.pl
Adres E-mail:
Wyślij wiadomość
Kategorie:
Zdrowie i profilaktyka » Laboratoria

Biomerieux Polska Sp. z o.o. - Aktualności


Biomérieux added 7 photos.



Wow, just in from our Canada subsidiary who are present at the CACMID Annual Conference, Victoria, BC, Canada. Looks like a beautiful place to go to learn about the latest in microbiology and infectious diseases! Pop in to our booth if you're there and say you saw this post! Don't forget we're holding a workshop, co-developed with AMMI Canada, on "The Need for MIC and Resistance Testing" on April 5 at 8-9 am in the Crystall Ballroom, Fairmont Expresss. You'll learn about the updates and advances ...
opublikowano na Facebook Napisz komentarz
Biomérieux created an event.

opublikowano na Facebook
Biomérieux added 6 photos.



We were extremely proud to welcome his Excellency, Mr. Xi Jinping, President of the People’s Republic of China to the bioMérieux (head office) in Marcy l’Etoile on Wednesday, March 26th. Mr Xi Jinping was accompanied by his wife and a large Chinese delegation, as well as by the Minister for Foreign Affairs of France and the Minister for Research for Higher Education of France and political representatives from the Rhone-Alps region. They were welcomed by Mr & Mrs Alain Mérieux and Mr & Mrs ...
opublikowano na Facebook Napisz komentarz
bioMérieux - 2013 Financial Results

Breaking news: bioMérieux's 2013 Financial results “...These results clearly attest to our Company’s competitiveness and strength. Despite a volatile currency environment, we will pursue our roadmap in 2014, which will therefore be a year of consolidation and investment ...." Objectives met - Solid financial performance - Sales up 4.6% at constant exchange rates and scope of consolidation - Operating income before non-recurring items: €262 million, or 16.5% of sales - Free cash flow: ...
opublikowano na Facebook
Biomérieux



bioMerieux’s involvement in DVT With over 15 years of experience in D-dimer testing, our VIDAS D-Dimer Exclusion II assay offers you high sensitivity and NPV, optimal precision at 500ng/mL cut-off and rapid 20 minute turn-around time, making it the right choice for your DVT / PE exclusion strategy. It's been 10 years since our test was first cleared by the FDA for the safe exclusion of PE and DVT in outpatients when used with clinical assessment. Considered the ‘’Gold Standard” by ...
opublikowano na Facebook Napisz komentarz
Biomérieux



Did you know that March is ”DVT Awareness Month”? Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) cause more deaths than more publicized conditions like breast cancer and motor vehicle accidents. - 1 person is diagnosed with a blood clot every minute - 1 person dies from a blood clot every six minutes Yet the majority of cases are preventable and treatable. Treatment requires an accurate diagnosis, which should be cost-effective without overuse of imaging.
opublikowano na Facebook Napisz komentarz
bioMérieux strengthens its Clostridium difficile offer with the launch of VIDAS® C....

Breaking news ! We've just launched our 100th VIDAS parameter! VIDAS® C. difficile GDH As you know Clostridium difficile, a major cause of healthcare-associated infections (HAI), is classified as an “urgent threat” in the CDC’s latest report on Antibiotic Resistance Threats. VIDAS® C. difficile GDH is the only FDA-approved automated immunoassay parameter for GDH detection Read more: http://www.biomerieux ...
opublikowano na Facebook
"@Medhat Taha, I see you're from..." on their own status.

opublikowano na Facebook
BioFire Submits 510(k) Application to FDA for FilmArray® Gastrointestinal Panel

Breaking news! BioFire Submits 510(k) Application to FDA for FilmArray Gastrointestinal Panel Read more: http://www.biomerieux.com/en/biofire-submits-510k-application-fda-filmarrayr-gastrointestinal-panel
opublikowano na Facebook
Biomérieux



Just in! A few photos from Medlab in Singapore. So let's share the experience! First time Vidas 3 was shown in Singapore & customers already want the analyzer!! A great talk was given by Mike Dunne about "Changing the face of diagnostics in healthcare" And Dr Laurent Poirel was on the booth sharing our combat of BE SMART with Resistance. Not forgetting Myla - connecting people on the stand as well as in real life... Did you know the bioMérieux Sigapore subsidiary has a website: http://www ...
opublikowano na Facebook Napisz komentarz